News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 73–108
- Matches
- 1468
- Sources here
- 20
- Companies here
- 19
Active search
1468 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Why Ondas Stock Is Sinking Today
Key Points Ondas posted huge sales growth in Q2, but its loss came in higher than expected. The company increased its full-year sales guidance. Ondas's big sales beat in the second quarter could be more important than its earnings miss. 10 stocks we like …
AQR Capital discloses 5.82% Vanda Pharmaceuticals (VNDA) ownership on 13G
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have disclosed a passive ownership stake of 5.82% in Vanda Pharmaceuticals Inc. (VNDA), amounting to 3,497,695 shares. The SEC filing, a Schedule 13G, indicates that these entities have shared voting power over 3,313,298 shares …
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Given Consensus Rating of "Moderate Buy" by Brokerages
Vanda Pharmaceuticals (NASDAQ:VNDA) has received a consensus "Moderate Buy" rating from eight brokerages, with an average 12-month price target of $13.70 despite recent reductions from some analysts. The company reported a larger-than-expected quarterly loss and missed revenue estimates, leading analysts to anticipate unprofitability for …
Wall Street Analysts Predict a 26.24% Upside in Monday.com (MNDY): Here's What You Should Know
Shares of Monday.com (MNDY) have gained 6.5% over the past four weeks to close the last trading session at $85.95, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going …
Ondas Holdings Inc. (ONDS) Reports Q2 Loss, Beats Revenue Estimates
Ondas Holdings Inc. (ONDS) reported a Q2 loss of $0.03 per share, surpassing the Zacks Consensus Estimate of a $0.07 loss, and beat revenue estimates with $83.77 million. While the company's shares have underperformed the S&P 500 this year, its current Zacks Rank #3 …
Ondas Wins Israeli Defense Tender for Next-Gen Tactical Attack Drones
Ondas Inc. ONDS recently secured a multi-million-dollar tender from the Israeli Ministry of Defense (IMOD) to develop and produce next-generation tactical attack drones, further driving its expansion into advanced autonomous defense systems. The program will focus on developing low-cost, scalable tactical attack drones designed …
Ondas Holdings Shares Fall Despite Record Q2 Revenue and Higher 2026 Guidance
Ondas Holdings (ONDS) shares fell 4% in premarket trading despite reporting record Q2 revenue of $83.8 million, significantly exceeding forecasts, and raising its full-year 2026 sales outlook to $525-$550 million. The decline was attributed to a wider-than-expected adjusted Q2 loss of $0.19 per share …
Revenue at Palantir-Backed Ondas Rises 1,236%. Stock Falls as Losses Widen.
Shares of Ondas declined Thursday after the autonomous drone maker and Palantir partner posted a wider-than-expected second-quarter loss, overshadowing a more than 1,200% increase in revenue. Ondas stock fell 4.2% to $9.36 in premarket trading on Thursday after ending Wednesday up 0.3%. The West …
Indaptus Therapeutics, Inc. 2Q 2026: Net loss $(1.79M), EPS $(0.02) — 10-Q Summary
Indaptus Therapeutics, Inc. reported a significant improvement in its financial results for the second quarter of 2026, with a net loss of $(1.79M) and EPS of $(0.02), primarily due to reduced R&D and G&A spending following the wind-down of its Decoy20 Phase 1 study. …
Indaptus Therapeutics (INDP) slashes R&D costs and bolsters cash after $12M raise
Indaptus Therapeutics (INDP) significantly reduced its operating expenses and net loss in Q2 2026, bolstering its cash reserves with a $12 million private placement. The company reported an 83% drop in R&D costs and a narrowed net loss of $1.8 million, while it evaluates …
Indaptus Therapeutics (Nasdaq: INDP) cuts losses and raises $12M in Q2
Indaptus Therapeutics (INDP) significantly reduced its net loss in Q2 2026 to $1.8 million from $5.2 million in the previous year, primarily due to an 83% cut in R&D and a 37% decline in G&A expenses as it halted its Decoy20 clinical program and …
StandardAero, Inc. $SARO Shares Sold by Trinity Street Asset Management LLP
Trinity Street Asset Management LLP reduced its stake in StandardAero (NYSE:SARO) by 4.5% in Q2 2026, selling 45,166 shares but still holding 949,492 shares valued at $28.4 million. Despite this, other institutional investors increased their positions, and analysts maintain a "Moderate Buy" rating with …
Honda (HMC) Q1 2027 Earnings Call Transcript
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 2:35 a.m. ET CALL PARTICIPANTS Executive Officer and Chief Financial Officer - Masao KawaguchiOperating Executive, Head of Accounting and Finance Unit - Sumihiro Takahashi TAKEAWAYS Operating Profit -- JPY 530.7 billion for the …
Sharemaestro market context Trend signal active 52 weeks +7.6% · Next-week setup positive 55.5%The Technical Signals Behind (SNDX) That Institutions Follow
Stock Traders Daily provides a technical analysis of Syndax Pharmaceuticals Inc. (NASDAQ: SNDX), highlighting a mid-channel oscillation pattern with positive near-term sentiment within a long-term strength context. The analysis details three institutional trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) and offers multi-timeframe …
(SMP) Volatility Zones as Tactical Triggers
The article analyzes Standard Motor Products Inc. (NYSE: SMP), identifying a neutral sentiment across all time horizons and a mid-channel oscillation pattern. It outlines three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis highlights an …
StandardAero CEO Russell Ford sells $1,230 in stock By Investing.com
StandardAero CEO Russell Ford sold 41 shares of common stock for $1,230 on August 10, 2026, as part of a Rule 10b5-1 trading plan. Following the sale, he directly holds 14,342 shares and indirectly owns 295,532 shares through a Family LLC. The company's stock …